Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 687.

https://doi.org/10.1182/blood-2024-194886

Published: 2024

Journal Articles

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Arjun Pandey, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4899.

https://doi.org/10.1182/blood-2024-207936

Published: 2024

Journal Articles

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Nihar Desai, Tommy Alfaro Moya, Arjun Law, Wilson Lam, Igor Novitzky-Basso, Ivan Pasic, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4896.

https://doi.org/10.1182/blood-2024-204123

Published: 2024

Journal Articles

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 4883.

https://doi.org/10.1182/blood-2024-204052

Published: 2024

Journal Articles

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Nihar Desai, Arjun Law, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2024-204140

Published: 2024

Journal Articles

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2024-202554

Published: 2024

Journal Articles

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Nihar Desai, Arjun Law, Christopher Lemieux, Keven Vachon, Kareem Jamani, Mohamed Elemary, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 7353.

https://doi.org/10.1182/blood-2024-211615

Published: 2024

Journal Articles

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

Tommy Alfaro, Nihar Desai, Maria Queralt Salas, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jeffrey H. Lipton, Fotios Michelis, Igor Novitzky-Basso, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7289.

https://doi.org/10.1182/blood-2024-205817

Published: 2024

Journal Articles

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Mohammed Kawari, Mariana Pinto Pereira, Mats Remberger, Ambrose Lau, Arjun Law, Rajat Kumar, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 2151.

https://doi.org/10.1182/blood-2024-204249

Published: 2024

Journal Articles

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Blood (2024) 144 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2024-202708

Published: 2024

Journal Articles

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Caden Chiarello, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios Michelis, Ivan Pasic, Auro Viswabandya, Igor Novitzky-Basso

Blood (2024) 144 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2024-203265

Published: 2024

Journal Articles

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Ahmed Alnughmush, Mats Remberger, Vathany Kulasingam, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 7358.

https://doi.org/10.1182/blood-2024-202535

Published: 2024

Journal Articles

Impact of Age on Hospitalization and Readmission on Post Allogeneic Stem Cell Transplantation Outcome, Single Center Experience

Eshrak Al-Shaibani, Shiyi Chen, Wilson Lam, Arjun Law, Ivan Pasic, Fotios Michelis, Auro Viswabandya, Dennis Dong Hwan Kim, Sr., Armin Gerbitz, Jeffrey H. Lipton, Jonas Mattson, Rajat Kumar

Blood (2021) 138 (Supplement 1): 4122.

https://doi.org/10.1182/blood-2021-146275

Published: 2021

Journal Articles

Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

Swe Mar Linn, Igor Novitzky-Basso, Elizabeth Shin, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.

Blood (2021) 138 (Supplement 1): 3896.

https://doi.org/10.1182/blood-2021-153045

Published: 2021

Journal Articles

Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival

Jennifer White, Mohamed Elemary, Swe Mar Linn, Igor Novitzky-Basso, Anargyros Xenocostas, Nada Hamad, Samantha Culos, Sui Tan, Arjun Law, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim, Sr.

Blood (2021) 138 (Supplement 1): 3905.

https://doi.org/10.1182/blood-2021-148859

Published: 2021

Journal Articles

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Igor Novitzky-Basso, Mats Remberger, Carol Chen, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2021) 138 (Supplement 1): 479.

https://doi.org/10.1182/blood-2021-151744

Published: 2021

Journal Articles

Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure

Igor Novitzky-Basso, Swe Mar Linn, Jennifer White, Mohamed Elemary, Anargyros Xenocostas, Nada Hamad, Sui Tan, Samantha Culos, Arjun Law, Dennis Dong Hwan Kim

Blood (2021) 138 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2021-151683

Published: 2021

Journal Articles

Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)

Swe Mar Linn, Igor Novitzky-Basso, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.

Blood (2021) 138 (Supplement 1): 1806.

https://doi.org/10.1182/blood-2021-152640

Published: 2021

Journal Articles

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Blood (2021) 138 (Supplement 1): 1791.

https://doi.org/10.1182/blood-2021-148497

Published: 2021

Journal Articles

Frailty Scale for Outcome Predictions in Hematopoietic Cell Transplanted Adults

Maria Queralt Salas, Eshetu G Atenafu, Eshrak Al-Shaibani, Ora Bascom, Leeann Wilson, Carol Chen, Ivan Pasic, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Fotios Michelis, Jonas Mattsson, Shabbir Alibhai, Rajat Kumar

Blood (2021) 138 (Supplement 1): 110.

https://doi.org/10.1182/blood-2021-153710

Published: 2021

NARROW

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Impact of Age on Hospitalization and Readmission on Post Allogeneic Stem Cell Transplantation Outcome, Single Center Experience

Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure

Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Frailty Scale for Outcome Predictions in Hematopoietic Cell Transplanted Adults

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only